Neil Kumar, BridgeBio

Neil Ku­mar bets near­ly $1B on what Bridge­Bio hopes will be their first big drug

Bridge­Bio CEO Neil Ku­mar fi­nal­ly won back full con­trol of the drug he let get (par­tial­ly) away.

On Mon­day, af­ter three failed at­tempts, Bridge­Bio pur­chased …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.